Efektivitas dan keamanan penggunaan probiotik terhadap mukositis oral yang diinduksi radiasi dan kemoterapi: Systematic review
Abstract
ABSTRAK
Pendahuluan: Mukositis oral adalah inflamasi mukosa mulut yang terjadi karena radioterapi atau kemoterapi pada penatalaksanaan kanker kepala dan leher, yang dapat menimbulkan beberapa tanda dan gejala antara lain lesi dengan bentuk ulserasi, eritema, rasa nyeri, disfagia dan malnutrisi. Radioterapi dan kemoterapi merupakan pilihan selain pembedahan dalam penatalaksanaan kanker kepala dan leher. Pemberian probiotik (lactobacillus dan bifidobacterium) merupakan salah satu alternatif terapi dalam penatalaksanaan mukositis oral. Tujuan tinjauan sistematik ini adalah untuk menganalisis efektivitas dan keamanan penggunaan probiotik untuk menurunkan insidensi, rasa nyeri, dan derajat keparahan pada mukositis oral.Metode: Penulisan tinjauan sistematik ini mengikuti pedoman PRISMA. Pencarian artikel dengan menggunakan database elektronik yaitu PubMed, EBSCO, Science Direct, dan Scopus. Populasi pada tinjauan sistematik ini adalah pasien yang terdiagnosis kanker kepala dan leher yang mengalami mukositis oral setelah mendapatkan terapi radiasi. Didapatkan lima artikel yang memenuhi kriteria pencarian yaitu, jurnal dengan teks lengkap dalam bahasa inggris dan menggunakan metode penelitian Randomized Controlled Trial (RCT). Hasil: Empat artikel menyatakan bahwa probiotik efektif dalam mengurangi tingkat insidensi terjadinya mukositis oral, rasa nyeri dan derajat keparahan mukositis oral melalui peningkatan imunitas pasien. Simpulan: Sebagian besar penelitian membuktikan penggunaan probiotik efektif dan aman dalam mengurangi insidensi, rasa nyeri, dan derajat keparahan pada mukositis oral.
KATA KUNCI: probiotik, lactobacillus, bifidobacterium, mukositis oral
The effectiveness and safety of probiotics for radiation and chemotherapy-induced oral mucositis: A Systematic Review
ABSTRACT
Introduction: Oral mucositis is inflammation of the oral mucosa that occurs due to radiotherapy or chemotherapy in the management of head and neck cancer and can cause several signs and symptoms, including ulcerated lesions, erythema, pain, dysphagia, and malnutrition. Radiotherapy and chemotherapy are options besides surgery in the management of head and neck cancer. Administration of probiotics (lactobacillus and bifidobacterium) is an alternative therapy in the management of oral mucositis. The aim of this systematic review was to analyze the effectiveness and safety of using probiotics to reduce the incidence, pain, and severity of oral mucositis. Method: The writing of this systematic review followed the PRISMA guidelines. Article search using electronic databases, namely PubMed, EBSCO, Science Direct, and Scopus The population in this systematic review was comprised of patients diagnosed with head and neck cancer who developed oral mucositis following radiation therapy. Five articles were found that met the search criteria, namely, journals with full text in English and using the randomized controlled trial (RCT) research method. Results: Four articles stated that probiotics were effective in reducing the incidence, pain, and severity of oral mucositis by increasing the patient's immunity. Conclusion: Most studies prove the use of probiotics to be effective and safe in reducing the incidence, pain, and severity of oral mucositis.
KEY WORDS: probiotics, lactobacillus, bifidobacterium, oral mucositis
Keywords
Full Text:
PDFReferences
DAFTAR PUSTAKA
Schmidt E. Diseases of the Oral Mucosa. Springer International Publishing; 2021. DOI: 10.1007/978-3-030-82804-2.
Glick M, Greenberg MS, Lockhart PB, Challacombe SJ. Burket’s Oral Medicine. 13th Ed; John Wiley & Sons Inc; 2021 1136. p.24-36
Farah C, Balasubramaniam R, Mccullough MJ. Contemporary Oral Medicine. Springer International Publishing; 2019. p. 1728, 2197–2198
Sonis ST. Pocket Books For Cancer Supportive Care Oral mucositis. Springer Healthcare; 2012. p.7,31-39
Scully C. Oral and Maxillofacial Medicine The Basis Of Diagnosis And Treatment. 3th Ed; Churcill livingstone Elsevier; 2013. p.373
Shetty SS, Maruthi M, Dhara V, de Arruda JAA, Abreu LG, Mesquita RA, et al. Oral mucositis: Current knowledge and future directions. Disease-a-Month. 2022; 68(5). DOI: 10.1016/j.disamonth.2021.101300
Cereda E, Caraccia M, Caccialanza R. Probiotics and mucositis. Curr Opin Clin Nutr Metab Care. 2018; 21(5): 399-404. DOI: 10.1097/MCO.0000000000000487.
Nair. SS, Prajapati JB. Probiotics: A Novel Natural Therapy For Oral Health. Int J Probiotics Prebiotics. 2018; Accesed from: https://www.nchpjournals.com/ManuscriptIjpp?id=1116
Fang F, Xu J, Li Q, Xia X, Du G. Characterization of a Lactobacillus brevis strain with potential oral probiotic properties. BMC Microbiol. 2018; DOI: 10.1186/s12866-018-1369-3
Picó JA, Monllor, Mingot JM, Ascencao. Search and selection of probiotics that improve mucositis symptoms in oncologic patients. A systematic review. Nutrients. MDPI AG; 2019. DOI: 10.3390/nu11102322
Surono_IS. Probiotik, Mikrobiome dan Pangan Fungsional. Penerbit Deepublish (Grup Penerbitan CV BUDI UTAMA ;2016. p.1-11,148-175.
Lee_YK, Salminen S. Handbook of Probiotics And Prebiotics. 2nd Ed; A John Wiley & Sons publication; 2019. p.3-24,75,94.
Venema K, Carmo AP. Probiotics and prebiotics : current research and future trends. Caister Academic Press; 2015. p.3-43.
Song D, Ibrahim S, Hayek S. Recent Application of Probiotics in Food and Agricultural Science. In: Probiotics. InTech; 2012. DOI: 10.5772/50121
Kumar DM, Amaresan N, Sankaranarayanan A, Kemp H. Probiotics in the Prevention and Management of Human Diseases A Scientific Perspective. Academic Press is an imprint of Elsevier; 2022. P.1-9,41-53251-259.
Xia C, Jiang C, Li W, Wei J, Hong H, Li J, et al. A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma. Front Immunol; 2021. DOI: 10.3389/fimmu.2021.618150
Mirza MA, Aruna D, Irukulla M. Efficacy of Bacillus clausii UBBC - 07 spores in the amelioration of oral mucositis in head and neck cancer patients undergoing radiation therapy. Cancer Treat Res Commun; 2022. DOI: 10.1016/j.ctarc.2022.100523
Sharma A, Rath GK, Chaudhary SP, Thakar A, Mohanti BK, Bahadur S. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study. Eur J Cancer; 2012. DOI: 10.1016/j.ejca.2011.06.010
Jiang C, Wang H, Xia C, Dong Q, Chen E, Qiu Y, et al. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma. Frontiers in immunology; 2019. DOI: 10.1002/cncr.31907
de Sanctis V, Belgioia L, Cante D, la Porta MR, Caspiani O, Guarnaccia R, et al. Lactobacillus brevis CD2 for Prevention of Oral Mucositis in Patients with Head and Neck Tumors: A multicentric randomized study. Anticancer Res; 2019. DOI: 10.21873/anticanres.13303
Liu Y, Tran DQ, Rhoads JM. Probiotics in Disease Prevention and Treatment. J Clin Pharmacol; 2018. DOI: 10.1002/jcph.1121
Kitazawa H, Villena J, Alvarez S. Probiotics: Immunobiotics and Immunogenics. CRC Press Taylor & Francis Group; 2014. p.12-36.
Floch MH, Ringel Y, Allen Walker W. The Microbiota in Gastrointestinal Pathophysiology. 1st Ed. Academic Press is an imprint of Elsevier; 2017. pp 442.
Sanders ME, Akkermans LMA, Haller D, Hamerman C, Heimbach J, Hormansperger G, Huys G, Levy DD, Lutgendorff F, Mack D, Phothirath P, Aguilar GS, Vaughn E, Safety Assessment of probiotics for human use. Landes bioscience; 2010. DOI: 10.4161/gmic.1.3.12127
Fallah M, Amin N, Moghadaisan MA, Jafarnejad S, probiotics for the management of oral mucositis: an interpretive review of current evidence. Adv Pharm Bull; 2023. DOI: 10.34172/apb.2023.029
DOI: https://doi.org/10.24198/pjdrs.v7i2.46400
Refbacks
- There are currently no refbacks.
Statistik Pengunjung
Padjadjaran Journal of Dental Researchers and Students dilisensikan di bawah Creative Commons Attribution 4.0 International License